Effectiveness of Influenza Vaccine in Preventing Medically-attended Influenza Virus Infection in Primary Care, Israel, Influenza Seasons 2014/15 and 2015/16

Overview

Journal Euro Surveill

Specialty Infectious Diseases

Date 2018 Feb 24

PMID 29471622

Citations 10

Authors

Hamutal Yaron-Yakoby

Hanna Sefty

Rakefet Pando

Rita Dichtiar

Mark A Katz

Yaniv Stein

Michal Mandelboim

Ella Mendelson

Tamy Shohat

Aharona Glatman-Freedman

Affiliations

Soon will be listed here.

Abstract

IntroductionInfluenza vaccine is recommended for the entire population in Israel. We assessed influenza vaccine effectiveness (VE) for the 2014/15 and 2015/16 seasons in Israel, for the first time. Combined nose and throat swab specimens were collected from patients with influenza-like illness (ILI) presenting to sentinel primary care clinics and tested for influenza virus by RT-PCR. VE of the trivalent inactivated vaccine (TIV) was assessed using test-negative case-control design. During the 2014/15 season 1,142 samples were collected; 327 (28.6%) were positive for influenza, 83.8% A(H3N2), 5.8% A(H1N1)pdm09, 9.2% B and 1.2% A un-subtyped. Adjusted VE against all influenza viruses for this influenza season was -4.8% (95% confidence interval (CI): -54.8 to 29.0) and against influenza A(H3N2), it was -15.8% (95% CI: -72.8 to 22.4). For the 2015/16 season, 1,919 samples were collected; 853 (44.4%) were positive for influenza, 43.5% A(H1N1)pdm09, 57% B, 0.7% A(H3N2) and 11 samples positive for both A(H1N1)pdm09 and B. Adjusted VE against all influenza viruses for this influenza season was 8.8% (95% CI: -25.1 to 33.5), against influenza A(H1N1)pdm09, it was 32.3% (95% CI: (-4.3 to 56.1) and against influenza B, it was -2.2% (95% CI: (-47.0 to 29.0). Using samples from patients with ILI visiting sentinel clinics in Israel, we demonstrated the feasibility of influenza VE estimation in Israel.

Citing Articles

AI-assisted diagnostic approach for the influenza-like illness in children: decision support system for patients and clinicians.

Lee Y, Seo J, Kim Y Biomed Eng Lett. 2025; 15(2):327-336.

PMID: 40026885 PMC: 11871169. DOI: 10.1007/s13534-024-00450-8.

Seasonal Influenza Vaccine Effectiveness in Persons Aged 15-64 Years: A Systematic Review and Meta-Analysis.

Martins J, Santos M, Martins A, Felgueiras M, Santos R Vaccines (Basel). 2023; 11(8).

PMID: 37631889 PMC: 10459161. DOI: 10.3390/vaccines11081322.

Decline in Seasonal Influenza Vaccine Effectiveness With Vaccination Program Maturation: A Systematic Review and Meta-analysis.

Okoli G, Racovitan F, Abdulwahid T, Hyder S, Lansbury L, Righolt C Open Forum Infect Dis. 2021; 8(3):ofab069.

PMID: 33738320 PMC: 7953658. DOI: 10.1093/ofid/ofab069.

Influenza A Virus Inhibits RSV Infection via a Two-Wave Expression of IFIT Proteins.

Drori Y, Jacob-Hirsch J, Pando R, Glatman-Freedman A, Friedman N, Mendelson E Viruses. 2020; 12(10).

PMID: 33081322 PMC: 7589235. DOI: 10.3390/v12101171.

Variations in Seasonal Influenza Vaccine Effectiveness due to Study Characteristics: A Systematic Review and Meta-analysis of Test-Negative Design Studies.

Okoli G, Racovitan F, Righolt C, Mahmud S Open Forum Infect Dis. 2020; 7(7):ofaa177.

PMID: 32704509 PMC: 7367680. DOI: 10.1093/ofid/ofaa177.

References

Jimenez-Jorge S, DE Mateo S, Delgado-Sanz C, Pozo F, Casas I, Garcia-Cenoz M . Estimating influenza vaccine effectiveness in Spain using sentinel surveillance data. Euro Surveill. 2015; 20(28). DOI: 10.2807/1560-7917.es2015.20.28.21187. View

Zimmerman R, Nowalk M, Chung J, Jackson M, Jackson L, Petrie J . 2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type. Clin Infect Dis. 2016; 63(12):1564-1573. PMC: 5146719. DOI: 10.1093/cid/ciw635. View

Kissling E, Valenciano M . Early influenza vaccine effectiveness results 2015-16: I-MOVE multicentre case-control study. Euro Surveill. 2016; 21(6). DOI: 10.2807/1560-7917.ES.2016.21.6.30134. View

Puig-Barbera J, Mira-Iglesias A, Tortajada-Girbes M, Lopez-Labrador F, Belenguer-Varea A, Carballido-Fernandez M . Effectiveness of influenza vaccination programme in preventing hospital admissions, Valencia, 2014/15 early results. Euro Surveill. 2015; 20(8). DOI: 10.2807/1560-7917.es2015.20.8.21044. View

Pebody R, Warburton F, Ellis J, Andrews N, Potts A, Cottrell S . Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results. Euro Surveill. 2016; 21(38). PMC: 5073201. DOI: 10.2807/1560-7917.ES.2016.21.38.30348. View

Belongia E, Simpson M, King J, Sundaram M, Kelley N, Osterholm M . Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis. 2016; 16(8):942-51. DOI: 10.1016/S1473-3099(16)00129-8. View

Petrie J, Ohmit S, Cheng C, Martin E, Malosh R, Lauring A . Influenza Vaccine Effectiveness Against Antigenically Drifted Influenza Higher Than Expected in Hospitalized Adults: 2014-2015. Clin Infect Dis. 2016; 63(8):1017-25. DOI: 10.1093/cid/ciw432. View

Radin J, Hawksworth A, Myers C, Ricketts M, Hansen E, Brice G . Influenza vaccine effectiveness: Maintained protection throughout the duration of influenza seasons 2010-2011 through 2013-2014. Vaccine. 2016; 34(33):3907-12. DOI: 10.1016/j.vaccine.2016.05.034. View

Bromberg M, Kaufman Z, Mandelboim M, Sefty H, Shalev V, Marom R . [Clinical and virological surveillance of influenza in Israel--implementation during pandemic influenza]. Harefuah. 2010; 148(9):577-82, 659. View

10.

Pebody R, Warburton F, Andrews N, Ellis J, von Wissmann B, Robertson C . Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results. Euro Surveill. 2015; 20(36). DOI: 10.2807/1560-7917.ES.2015.20.36.30013. View

11.

Al-Abdallat M, Dawson P, Haddadin A, El-Shoubary W, Dueger E, Al-Sanouri T . Influenza hospitalization epidemiology from a severe acute respiratory infection surveillance system in Jordan, January 2008-February 2014. Influenza Other Respir Viruses. 2015; 10(2):91-7. PMC: 4746565. DOI: 10.1111/irv.12354. View

12.

Saito N, Komori K, Suzuki M, Morimoto K, Kishikawa T, Yasaka T . Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan. Vaccine. 2017; 35(4):687-693. DOI: 10.1016/j.vaccine.2016.11.024. View

13.

Davlin S, Blanton L, Kniss K, Mustaquim D, Smith S, Kramer N . Influenza Activity - United States, 2015-16 Season and Composition of the 2016-17 Influenza Vaccine. MMWR Morb Mortal Wkly Rep. 2016; 65(22):567-75. DOI: 10.15585/mmwr.mm6522a3. View

14.

Valenciano M, Kissling E, Reuss A, Jimenez-Jorge S, Horvath J, Donnell J . The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2). Vaccine. 2015; 33(24):2813-22. DOI: 10.1016/j.vaccine.2015.04.012. View

15.

Pebody R, Warburton F, Ellis J, Andrews N, Thompson C, von Wissmann B . Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results. Euro Surveill. 2015; 20(5):21025. View

16.

Sharabi S, Drori Y, Micheli M, Friedman N, Orzitzer S, Bassal R . Epidemiological and Virological Characterization of Influenza B Virus Infections. PLoS One. 2016; 11(8):e0161195. PMC: 4988634. DOI: 10.1371/journal.pone.0161195. View

17.

Hindiyeh M, Goulding C, Morgan H, Kenyon B, Langer J, Fox L . Evaluation of BioStar FLU OIA assay for rapid detection of influenza A and B viruses in respiratory specimens. J Clin Virol. 2000; 17(2):119-26. DOI: 10.1016/s1386-6532(00)00081-0. View

18.

Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M . In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature. 2009; 460(7258):1021-5. PMC: 2748827. DOI: 10.1038/nature08260. View

19.

Hindiyeh M, Ram D, Mandelboim M, Meningher T, Hirsh S, Robinov J . Rapid detection of influenza A pandemic (H1N1) 2009 virus neuraminidase resistance mutation H275Y by real-time reverse transcriptase PCR. J Clin Microbiol. 2010; 48(5):1884-7. PMC: 2863859. DOI: 10.1128/JCM.02540-09. View

20.

Mandelboim M, Glatman-Freedman A, Drori Y, Sherbany H, Pando R, Sefty H . Ineffectiveness of the 2014-2015 H3N2 influenza vaccine. Oncotarget. 2015; 7(2):1185-92. PMC: 4811452. DOI: 10.18632/oncotarget.6746. View